To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension

Clinical trial NCT02047656 · TERMINATED

Trial details

NCT number: NCT02047656
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Part 1 - Healthy Volunteers Part 2 - Patients With Hypertension

Start date: 2013-08-01
Primary completion: 2014-08-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.